THUNDEROBOT
872190
Ji Yao Holding Group
300108
Hangzhou Huasu Technology
301157
Flaircomm Microelectronics, Inc.
301600
Jiusheng Electric
301082
CN Stock MarketDetailed Quotes
688073 Bide Pharmatech
- 47.20
- -0.65-1.36%
Market Closed Jan 7 15:00 CST
4.29BMarket Cap53.58P/E (TTM)
48.90High45.87Low12.27KlotVolume47.47Open47.85Pre Close57.78MTurnover2.84%Turnover Ratio39.14P/E (Static)90.88MShares53.2852wk High2.15P/B2.04BFloat Cap28.5052wk Low57.42Limit Up43.23MShs Float112.07Historical High38.28Limit Down6.33%Amplitude28.50Historical Low0.90Dividend TTM47.10Avg Price6.83KlotAsk1.91%Div YieldTTM100Lot Size4.49KlotBid
Bide Pharmatech News
Bide Pharmaceutical: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Bide Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Announcement on the resignation of the company\'s core technical personnel and the addition of certified core technical personnel
Bide Pharmaceutical: 2025 First Extraordinary General Meeting of Shareholders Meeting Information
Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Haitong Securities Co., Ltd. inspection opinion on the departure of the director, deputy general manager and core technical personnel of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement on the resignation of the company\'s director, deputy general manager and core technical personnel
Bide Pharmaceutical: An indicative announcement on the actual controller of the company\'s proposal that the company buy back the shares again
Announcement on shareholders\' completion of non-transactional account transfers
Bide Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Bide Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Bide Pharmaceutical: 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on changing part of the content of the fund-raising project and extending the implementation period
Announcement on plans to launch foreign exchange hedging business
Announcement on plans to use idle own funds for cash management